Professor of Ophthalmology at University of Paris and Head of the department of Ophthalmology at Lariboisière University Hospital (Paris, France). He has authored more than 140 medical and scientific articles and has made numerous contributions to ophthalmology textbooks. Dr. Tadayoni completed undergraduate training in medicine at the University of Marseille, and his M.D. and internship at Paris V University. He completed his studies with a retina fellowship at Lariboisière University Hospital. Simultaneously, he pursued his Ph.D. in Science at Paris VII University and the Paris Vision Institute.

Anat Loewenstein, M.D., MHA, is Professor of Ophthalmology, Chairman of the Division of Ophthalmology at the Tel Aviv Medical Center, Sidney Fox Chair of Ophthalmology at the Sackler Faculty of Medicine at Tel Aviv University, President of the Israeli Ophthalmological Society, and the General Secretary of the EURETINA board. She is a renowned retina specialist, expert in retinal toxicity, and has a strong research interest in the early detection of macular degeneration, among others. She currently serves as the Editor in Chief of the Journal Case Reports in Ophthalmology, is an associate editor of Investigative Ophthalmology & Visual Science Journal, European Journal of Ophthalmology and of Ophthalmologica. Pr. Loewenstein published more than 450 papers in peer reviewed journals and contributed multiple chapters to ophthalmology textbooks. She is also actively involved as a leader in mentorship of young retina specialists including the mentorship educational programs of ARVO and EURETINA.

.

Kuldev Singh is Professor of Ophthalmology and Chief of the Glaucoma Division at the Stanford University School of Medicine. He received an undergraduate degree in Biology and Economics from McGill University, MD and MPH degrees from the Johns Hopkins University followed by residency training at the Casey Eye Institute. He completed a Dana Foundation Fellowship at the Wilmer Eye Institute and a Heed Foundation Fellowship at the Bascom Palmer Eye Institute. Dr. Singh has published over 250 original peer-reviewed articles and delivered over 350 invited lectures including over 70 named or keynote lectures and visiting professorships, edited three textbooks, and served on the editorial boards of 11 ophthalmic publications. His clinical practice focuses on the medical, laser and surgical management of glaucoma and cataract. Dr. Singh has served as President of the American Glaucoma Society, Executive Vice President of the World Glaucoma Association and Board Chair for the Glaucoma Research Foundation. He serves on an FDA Advisory Committee and on the Executive Committee of the UCSF/Stanford Center for Excellence in Regulatory Science and Innovation (CERSI). Dr. Singh has received the World Glaucoma Association Founder’s Award, the Lifetime Achievement Honor Award from the American Academy of Ophthalmology and was inducted into the Delta Omega Public Health Honor Society at the Johns Hopkins University Bloomberg School of Public Health as a distinguished alumnus.

Pablo Villoslada, M.D., is an Adjunct Professor at Stanford University. He has been active in neuroscience and brain diseases research for more than 20 years, contributing to the application of systems biology to neurological diseases, development of new therapies or biomarkers for multiple sclerosis and neuro-ophthalmologic diseases, and developing new neuroimaging technologies for monitoring brain diseases. Prior to taking up his position at Stanford, he was Medical Director of Neuroinflammation at Genentech. His experience also includes roles as Adjunct Professor at the Department of Neurology, University of California, San Francisco, and Group Leader of the Neuroimmunology group of the Institute of Biomedical Research August Pi Sunyer (IDIBAPS), Hospital Clinic, University of Barcelona. He received his M.D. at the University of Santiago de Compostela, Spain in 1990, his speciality in neurology in 1995 at the Hospital Vall d’Hebron, Spain and his PhD in neuroimmunology in 1996 at the Autonomous University of Barcelona.